New OWEAR Program Highlights Emerging De Facto Standards in Open-source Algorithms
The Open Wearables Initiative (OWEAR) announced a new program designed to identify and support open-source algorithms that are being adopted rapidly and may become de facto industry standards.
This OWEAR program uses the number and quality of references to “crowdsource” the identification of potential de facto standards. Once a potential standard is identified, OWEAR will create and maintain a searchable catalog that displays key information about the studies in which the algorithm has been employed, including the therapeutic area, population(s) studied, and number of participants.
OWEAR plans to create a new catalog for each open-source algorithm used in a wearable sensor or other connected health technology that generates more than 25 published papers and meets other quality metrics. The reference-count criterion indicates that the algorithm has garnered significant industry adoption. Shimmer Research, Inc. has agreed to donate the staff time to create and maintain these OWEAR catalogs.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
